No abstract available
MeSH terms
-
Adalimumab
-
Alefacept
-
Anisoles / therapeutic use
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents / therapeutic use
-
Antioxidants / therapeutic use
-
Antiprotozoal Agents / therapeutic use
-
Antirheumatic Agents / therapeutic use
-
Atomoxetine Hydrochloride
-
Attention Deficit Disorder with Hyperactivity / drug therapy
-
Drug Approval*
-
Drug Therapy / nursing
-
Drug Therapy / standards
-
Drug Therapy / trends*
-
Fabry Disease / drug therapy
-
Gefitinib
-
Humans
-
Iduronidase / therapeutic use
-
Indoles / therapeutic use
-
Isoenzymes / therapeutic use
-
Lentigo / drug therapy
-
Lung Neoplasms / drug therapy
-
Migraine Disorders / drug therapy
-
Mucopolysaccharidosis I / drug therapy
-
Nitro Compounds
-
Patient Education as Topic
-
Propylamines / therapeutic use
-
Psoriasis / drug therapy
-
Pyrrolidines / therapeutic use
-
Quinazolines / therapeutic use
-
Recombinant Fusion Proteins / therapeutic use
-
Serotonin Receptor Agonists / therapeutic use
-
Thiazoles / therapeutic use
-
Tryptamines
-
alpha-Galactosidase / therapeutic use
Substances
-
Anisoles
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Antioxidants
-
Antiprotozoal Agents
-
Antirheumatic Agents
-
Indoles
-
Isoenzymes
-
Nitro Compounds
-
Propylamines
-
Pyrrolidines
-
Quinazolines
-
Recombinant Fusion Proteins
-
Serotonin Receptor Agonists
-
Thiazoles
-
Tryptamines
-
eletriptan
-
Atomoxetine Hydrochloride
-
mequinol
-
alpha-Galactosidase
-
Iduronidase
-
Alefacept
-
Adalimumab
-
agalsidase beta
-
Gefitinib
-
nitazoxanide